On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...